Kimberly-Clark's analyst price target was modestly increased from $128.63 to $128.87, as analysts factor in stable sales performance and balanced risks from recent strategic moves.
Analyst Commentary
Following recent developments for Kimberly-Clark, analysts have offered a mix of optimism and caution regarding the company's outlook. The responses revolve around the planned acquisition of Kenvue, performance in core categories, and overall valuation considerations.
Bullish Takeaways- Bullish analysts highlighted the company's stable organic sales, particularly in challenging segments like the U.S. diaper category. This stability supported upward adjustments to price targets.
- Strategic acquisitions, such as the deal with Kenvue, are viewed as opportunities to strengthen Kimberly-Clark’s brand portfolio at an attractive price. This is seen as an indication of potential for long-term growth.
- Some upgrades and raised targets reflect confidence that Kimberly-Clark remains well-positioned despite competitive pressures, with recent quarterly results cited as evidence of resilience.
- The possibility of additional interested parties in Kenvue, if deal visibility improves, is seen as potentially beneficial. This contributes to positive speculation around future portfolio value.
- Bearish analysts lowered price targets due to concerns related to execution risk around the Kenvue acquisition. They emphasized uncertainty over integration and outcomes of key legal or portfolio-related cases.
- The cautious outlook reflects muted and decelerating growth trends in segments of the personal care market, leading to more conservative valuation adjustments.
- Some analysts maintain a wait-and-see approach, noting the increased risk to Kimberly-Clark’s stock valuation arising from near-term deal-related volatility.
- Ongoing competitive dynamics in core categories introduce additional uncertainty that could affect future sales performance and margins.
What's in the News
- Kimberly-Clark's planned acquisition of Kenvue has enabled activist investor D.E. Shaw to avoid significant losses. Other major investors, such as Toms Capital, plan to retain their Kenvue shares after the deal (The Wall Street Journal).
- Kimberly-Clark updated its 2025 earnings guidance, forecasting low single digit adjusted operating profit growth and low to mid single digit adjusted EPS growth on a constant-currency basis. This outlook factors in ongoing business exits and divestitures.
- The company completed another tranche of its share buyback program, repurchasing nearly 140,000 shares for $18 million. This brings total buybacks since 2021 to over 9.18 million shares.
- Kimberly-Clark announced four expanded charitable partnerships aimed at improving essential care for women and girls across seven countries. These partnerships are expected to benefit an estimated 24 million people over three years through a $28.7 million commitment.
Valuation Changes
- Consensus Analyst Price Target has increased slightly, moving from $128.63 to $128.87.
- Discount Rate has edged down marginally, from 6.956% to 6.956%.
- Revenue Growth projection remains essentially unchanged at approximately 7.01%.
- Net Profit Margin is virtually flat, rising fractionally from 11.10% to 11.10%.
- Future P/E ratio has risen modestly from 19.18x to 19.51x.
Have other thoughts on Kimberly-Clark?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
